Publisher
Springer International Publishing
Reference31 articles.
1. Rybak JM, Roberts K. Tedizolid phosphate: a next-generation oxazolidinone. Infect Dis Ther. 2015;4:1–4.
2. Tsuji BT, Kaatz GW, Rybak MJ. Linezolid and other oxazolidinones. Infect Dis Antimicrob Agents; www.antimicrobe.org/new/d13.asp
3. Zhanel GG, Shroeder C, Vercaigne L, Gin AS, Embil J, Hoban DJ. A critical review of oxazolidinones: an alternative or replacement for glycopeptides and streptogramins? Can J Infect Dis. 2001;12:379–90.
4. Davidson N, Grigg MJ, Mcguiness SL, Baird RJ, Anstey NM. Safety and outcomes of linezolid use for nocardiosis. Open Forum Infect Dis. 2020;7:ofaa090.
5. Conradie F, Diacon AH, Ngubane N, et al. Treatment of highly drug-resistant pulmonary tuberculosis. N Engl J Med. 2020;382:893–902.